1. Home
  2. SRFM vs BHST Comparison

SRFM vs BHST Comparison

Compare SRFM & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Surf Air Mobility Inc.

SRFM

Surf Air Mobility Inc.

HOLD

Current Price

$1.32

Market Cap

123.3M

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$4.33

Market Cap

104.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SRFM
BHST
Founded
2011
2007
Country
United States
Canada
Employees
N/A
87
Industry
Transportation Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
104.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
SRFM
BHST
Price
$1.32
$4.33
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$3.25
$12.00
AVG Volume (30 Days)
2.0M
16.2K
Earning Date
03-12-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
45.69
N/A
EPS
N/A
N/A
Revenue
$106,557,000.00
N/A
Revenue This Year
$10.33
$116.40
Revenue Next Year
$66.62
$55.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$4.10
52 Week High
$9.35
$12.80

Technical Indicators

Market Signals
Indicator
SRFM
BHST
Relative Strength Index (RSI) 24.15 44.48
Support Level N/A $4.19
Resistance Level $2.20 $5.02
Average True Range (ATR) 0.15 0.24
MACD -0.05 0.03
Stochastic Oscillator 1.15 31.08

Price Performance

Historical Comparison
SRFM
BHST

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: